Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 341 of 6351
-
Could a new drug beat the current standard for septic shock?
Disease control Not yet recruitingDespite best therapy efforts, sepsis and septic shock are associated with mortality rates of up to 40%. This clinical trial will determine the benefit of exogenous Angiotensin II versus norepinephrine (conventional care) treatment in septic shock patients. This trial will determi…
Phase 4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Heart procedure may offer lasting migraine relief, new study hopes to prove
Symptom relief Not yet recruitingMigraine is a common and often disabling condition, but its exact causes are not fully understood. Some people with migraines have a small opening in the heart wall called a patent foramen ovale (PFO). In some of these patients, closing this opening or taking a medication that in…
Phase 3 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New hope for bipolar depression? pramipexole trial targets anhedonia
Symptom relief Not yet recruitingAmong psychiatric disorders, bipolar disorder stands out due to its alarmingly high suicide rates. This condition presents unique management challenges, especially during its depressive phase, which carries the highest risk of suicide. B-HAPPI is an academic randomized controlled…
Phase 3 • Sponsor: Daniel Lindqvist • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could removing the primary tumor boost survival in stage IV breast cancer with Bone-Only spread?
Disease control Not yet recruitingThis is a national multicenter, prospective, randomized controlled trial. The study aims to compare the 5-year overall survival (OS) between patients receiving primary tumor surgery followed by systemic therapy (surgery group) and those receiving systemic therapy alone (non-surge…
Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a sleep drug curb heavy drinking? new trial investigates
Disease control Not yet recruitingThe goal of this clinical trial is to see if a sleep medication, daridorexant (DTX), can help decrease drinking in people who have alcohol use disorder (AUD) and insomnia. The main questions it aims to answer are: * Can DTX decrease alcohol use in individuals with insomnia bett…
Phase 2 • Sponsor: Sterling McPherson • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can a nerve zap ease bladder urgency after stroke?
Symptom relief Not yet recruitingThis study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke. Primary Hypothesis: PTNS …
Sponsor: Kutahya Health Sciences University • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Heart valve fix without the hospital stay? trial tests Same-Day discharge
Disease control Not yet recruitingTranscatheter aortic valve implantation (TAVI) has become the standard treatment for patients with severe aortic stenosis across a broad range of surgical risk. Advances in device technology and procedural techniques have enabled minimalist approaches and shorter hospital stays. …
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a common blood pressure drug protect the placenta in Early-Onset preeclampsia?
Disease control Not yet recruitingEarly-onset preeclampsia (PE), defined as preeclampsia presenting before 34 weeks of gestation, is a severe placental disorder associated with significant maternal and perinatal morbidity. There is currently no disease-modifying treatment; management relies on close surveillance …
Phase 1/2 • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
A new lens design might stop adult nearsightedness from worsening
Disease control Not yet recruitingMyopia (nearsightedness) can continue to worsen during young adulthood, increasing the risk of sight-threatening eye diseases later in life. Although dual-focus soft contacts (DFSC) lenses have been shown to slow myopia progression in children, their effectiveness in adults is no…
Sponsor: University of California, Berkeley • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can antibody infusions outperform antibiotics in shielding CAR-T patients from infections?
Disease control Not yet recruitingB cell (CD19) targeted chimeric antigen receptor modified T Cells (CAR-T) has transformed treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) or B-cell lymphoma (BCL). Because patients receiving CAR-T often present uncontrolled disease and have undergone…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Which embolic agent works best for brain bleeding? a trial aims to find out
Disease control Not yet recruitingSingle site, prospective, comparative effectiveness pilot trial comparing efficacy and safety outcomes of three embolic materials (particles, liquid embolics, and Wallaby Phenox coils) in MMA embolication for cSDH.
Sponsor: Sanford Health • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a One-Year bone drug switch beat standard therapy for Steroid-Induced bone loss?
Disease control Not yet recruitingThis is an extended observation study of a RCT comparing the efficacy of romorozumab and denosumab in high-risk patients using long-term glucocorticoids. In the romosozumab arm, patients were shifted to denosumab after the first year. The denosumab arm of patients were continued …
Phase 4 • Sponsor: Tuen Mun Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new antibody tame lupus flares?
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase II study designed to evaluate the efficacy and safety of ESG206 in participants with Systemic Lupus Erythematosus (SLE).
Phase 2 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
NASA tests blue light and meal timing to keep pilots sharp on Long-Haul flights
Symptom relief Not yet recruitingThe purpose of the present study is to test novel countermeasures to reduce fatigue among airline pilots during long-haul flight operations. The investigators will collect objective and subjective sleep, sleepiness, workload, and performance data from active-duty line pilots flyi…
Sponsor: National Aeronautics and Space Administration (NASA) • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can a less invasive disc surgery mean less pain right after?
Knowledge-focused Not yet recruitingThe lifetime prevalence of lumbosacral radiculopathy is 3 to 5 percent. The most common cause is a lumbar disc herniation. In 10 to 20 percent of patients, medical treatment is insufficient, and surgery is recommended. Lumbar discectomy is the standard surgical treatment. In rece…
Sponsor: Saint-Gregoire Private Hospital Center • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can targeted brain pulses quiet chronic anxiety?
Disease control Not yet recruitingThis randomized, rater-blinded clinical trial evaluates the effectiveness, safety, and tolerability of continuous theta burst stimulation (cTBS) in adults with generalized anxiety disorder (GAD). Participants will be randomly assigned in a 1:1 ratio to receive cTBS targeting eith…
Sponsor: Military Hospital 175 • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
Rewiring young brains: can targeted drills ease math struggles?
Knowledge-focused Not yet recruitingThe purpose of this study is to investigate neurocognitive mechanisms underlying response to intervention aimed at enhancing and remediating weaknesses in arithmetic skills in children, including those with mathematical learning disabilities.
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Can a culturally adapted workshop break the cycle of HIV stigma?
Disease control Recruiting nowThe goal of this study is to develop and test KABAWIL, a culturally tailored intervention designed to reduce HIV-related and intersectional stigmas experienced by Indigenous communities in Guatemala and improve engagement across the HIV Continuum of Care. The study will also asse…
Phase 1 • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A gentle nerve zap may calm an overactive bladder
Symptom relief Not yet recruitingThe aim of the project is to study neuromodulation treatment in patients with idiopathic overactive bladder syndrome (OAB) in real clinical practice.
Sponsor: University Hospital Ostrava • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can an antidepressant unblock stubborn constipation?
Disease control Not yet recruitingThis single-center, randomized, double-blind, placebo-controlled trial evaluates the efficacy and safety of fluoxetine (40 mg/day) versus placebo in 194 adults with refractory chronic constipation exhibiting Somatic Symptom Disorder (SSD) features diagnosed by SCID-5. After a 2-w…
Phase 2 • Sponsor: Zhifeng Zhao, PhD • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC